| Item Type | Name |
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Induction Chemotherapy
|
|
Concept
|
Drug Therapy
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Academic Article
|
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
|
|
Academic Article
|
Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
|
|
Academic Article
|
Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy.
|
|
Academic Article
|
Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?
|
|
Academic Article
|
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials.
|
|
Academic Article
|
Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
|
|
Academic Article
|
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
|
|
Academic Article
|
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
|
|
Academic Article
|
Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings.
|
|
Academic Article
|
Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
|
|
Academic Article
|
Adjuvant therapy for pancreatic cancer: current status, future directions.
|
|
Academic Article
|
Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
|
|
Academic Article
|
Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
|
|
Academic Article
|
Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal".
|
|
Academic Article
|
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
|
|
Academic Article
|
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
|
|
Academic Article
|
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
|
|
Academic Article
|
Management of a patient with borderline resectable pancreatic cancer. Case report and review.
|
|
Academic Article
|
Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.
|
|
Academic Article
|
Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer.
|
|
Academic Article
|
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.
|
|
Academic Article
|
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
|
|
Academic Article
|
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.
|
|
Academic Article
|
Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful?
|
|
Academic Article
|
Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma.
|
|
Academic Article
|
Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer.
|
|
Academic Article
|
The hematopoietic toxicity of regional radiation therapy. Correlations for combined modality therapy with systemic chemotherapy.
|
|
Academic Article
|
Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
|
|
Academic Article
|
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
|
|
Academic Article
|
Phase II study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia.
|
|
Academic Article
|
Amplification of circulating granulocyte-monocyte stem cell numbers following chemotherapy in patients with extensive small cell carcinoma of the lung.
|
|
Academic Article
|
Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head.
|
|
Academic Article
|
The clinical use of multimodality therapy in the management of cancer.
|
|
Academic Article
|
Improved survival for hepatocellular cancer with combination surgery and multimodality treatment.
|
|
Academic Article
|
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
|
|
Academic Article
|
Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.
|
|
Academic Article
|
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
|
|
Academic Article
|
Role of radiation therapy in the management of the patient with pancreatic cancer.
|
|
Academic Article
|
p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.
|
|
Academic Article
|
Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
|
|
Academic Article
|
Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
|
|
Academic Article
|
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
|
|
Academic Article
|
Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma?
|
|
Academic Article
|
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
|
|
Academic Article
|
Adjuvant therapy for pancreatic adenocarcinoma.
|
|
Academic Article
|
Continuing controversy over adjuvant therapy of pancreatic cancer.
|
|
Academic Article
|
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
|
|
Academic Article
|
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.
|
|
Academic Article
|
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031.
|
|
Academic Article
|
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.
|
|
Academic Article
|
Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity.
|
|
Academic Article
|
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
|